• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Pediatr . Community-Onset SARS-CoV-2 Infection in Young Infants: A Systematic Review

tetano

Editor, Senior Moderator
J Pediatr


. 2020 Sep 7;S0022-3476(20)31133-1.
doi: 10.1016/j.jpeds.2020.09.008. Online ahead of print.
Community-Onset SARS-CoV-2 Infection in Young Infants: A Systematic Review


Elyse G Mark[SUP] 1 [/SUP], W Christopher Golden[SUP] 1 [/SUP], Maureen M Gilmore[SUP] 1 [/SUP], Anna Sick-Samuels[SUP] 2 [/SUP], Melanie S Curless[SUP] 3 [/SUP], Lawrence M Nogee[SUP] 1 [/SUP], Aaron M Milstone[SUP] 2 [/SUP], Julia Johnson[SUP] 4 [/SUP]



Affiliations

Abstract

Objective: To summarize and evaluate current reports on community-onset severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in young infants.
Study design: We performed a systematic review to identify reports published from November 1, 2019, until June 15, 2020, on laboratory-confirmed community-onset SARS-CoV-2 infection in infants less than 3 months of age. We excluded studies reporting neonates with perinatal COVID exposure and diagnosis prior to hospital discharge and hospital-onset disease, as well as clinically diagnosed cases without confirmation. Two independent reviewers performed study screening, data abstraction, and risk of bias assessment. Variables of interest included patient age, exposure to COVID-19, past medical history, clinical symptoms, SARS-CoV-2 testing, laboratory findings, clinical course, and disposition.
Results: 38 publications met inclusion criteria, including 23 single case reports, 14 case series, and 1 cohort study, describing 63 infants under 3 months of age with laboratory confirmed SARS-CoV-2 infection. Most cases were mild to moderate. Fever, respiratory, gastrointestinal, cardiac, and neurologic findings were reported. Laboratory abnormalities included neutropenia, lymphopenia, and elevated serum levels of inflammatory markers and aminotransferases. Fifty-eight (92%) infants were hospitalized, 13 (21%) were admitted to the intensive care unit (ICU), and 2 (3%) required mechanical ventilation. No death was reported.
Conclusions: Among young infants with laboratory-confirmed SARS-CoV-2 infection, most cases were mild to moderate and improved with supportive care. Our results demonstrate a need for a high index of suspicion for SARS-CoV-2 infection in young infants presenting with generalized symptoms such as fever or decreased feeding, even in the absence of respiratory symptoms.

Keywords: neonate; pediatric; severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom